Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Their primary function is to lower serum glucose levels and thereby manage metabolism, per the organization
Another study, the PIONEER 6 trial, found that while semaglutide did not significantly increase the risk of major heart problems, some participants did report palpitations and high blood pressure
The company added that it will also sell brand-name versions of GLP-1 drugs, once supply rebounds
Developer: Novo Nordisk | Forms: Once-weekly injection or once-daily oral tablet Latest 2026 Update: FDA approved oral Wegovy (semaglutide 25 mg tablets) for weight loss in Dec 2025launched early 2026with ~16.6-17% average weight loss in OASIS 4 trial
US$ 28.92
US$ 22.95
US$ 28.12
